- Home
- IVA vs SLND Comparison
IVA vs SLND Comparison
Compare IVA & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- SLND
- Stock Information
- Founded
- IVA 2011
- SLND 1900
- Country
- IVA France
- SLND United States
- Employees
- IVA N/A
- SLND N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- IVA Health Care
- SLND Industrials
- Exchange
- IVA Nasdaq
- SLND Nasdaq
- Market Cap
- IVA 162.8M
- SLND 175.8M
- IPO Year
- IVA 2020
- SLND N/A
- Fundamental
- Price
- IVA $3.10
- SLND $3.04
- Analyst Decision
- IVA Strong Buy
- SLND Strong Buy
- Analyst Count
- IVA 4
- SLND 1
- Target Price
- IVA $13.25
- SLND $5.00
- AVG Volume (30 Days)
- IVA 8.3K
- SLND 45.1K
- Earning Date
- IVA 03-26-2025
- SLND 05-12-2025
- Dividend Yield
- IVA N/A
- SLND N/A
- EPS Growth
- IVA N/A
- SLND N/A
- EPS
- IVA N/A
- SLND N/A
- Revenue
- IVA $15,243,814.00
- SLND $980,179,000.00
- Revenue This Year
- IVA $18.05
- SLND $4.06
- Revenue Next Year
- IVA $46.74
- SLND $7.16
- P/E Ratio
- IVA N/A
- SLND N/A
- Revenue Growth
- IVA N/A
- SLND N/A
- 52 Week Low
- IVA $1.53
- SLND $1.85
- 52 Week High
- IVA $3.98
- SLND $5.98
- Technical
- Relative Strength Index (RSI)
- IVA 58.49
- SLND 42.09
- Support Level
- IVA $2.88
- SLND $3.15
- Resistance Level
- IVA $3.10
- SLND $3.23
- Average True Range (ATR)
- IVA 0.19
- SLND 0.12
- MACD
- IVA -0.01
- SLND -0.04
- Stochastic Oscillator
- IVA 72.07
- SLND 18.68
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.